India’s Repotrectinib: 60 Capsules ROS1/ALK Inhibitor

It’s this inhibitor called Repotrectinib that’s used to treat a type of lung cancer. It’s mainly used for two types: one that tests positive for ROS1 and another with NTRK fusion mutations. So, it’s a big shot inhibitor that goes after these TRK, ROS1, and ALK kinases.

The medication is formulated as 40 mg capsules and the prescribed dosing regimen consists of an initial 160 mg once daily for the first 14 days, followed by a maintenance dose of 160 mg taken twice daily. And you’ll get it in a bottle with 60 caps.